Want to see JP:6039 full AI Analyst Report?
Japan Animal Referral Medical Center Co., Ltd. (6039) Stock Statistics & Valuation Metrics
Total Valuation
Japan Animal Referral Medical Center Co., Ltd. has a market cap or net worth of JPY 13.86B. The enterprise value is JPY 17.45B.
- Market Cap
- JPY 13.86B
- Enterprise Value
- JPY 17.45B
Share Statistics
Japan Animal Referral Medical Center Co., Ltd. has 14,391,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 14,391,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.45%
Financial Efficiency
Japan Animal Referral Medical Center Co., Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 8.18%.
- Return on Equity (ROE)
- 0.17
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.18%
- Return on Capital Employed (ROCE)
- 0.15
- Revenue Per Employee
- 18.88M
- Profits Per Employee
- 2.54M
- Employee Count
- 328
- Asset Turnover
- 0.55
- Inventory Turnover
- 39.45
Valuation Ratios
The current PE Ratio of Japan Animal Referral Medical Center Co., Ltd. is 14.00. Japan Animal Referral Medical Center Co., Ltd.’s PEG ratio is 0.28.
- PE Ratio
- 14.00
- PS Ratio
- 1.96
- PB Ratio
- 2.52
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.28
Income Statement
In the last 12 months, Japan Animal Referral Medical Center Co., Ltd. had revenue of 6.19B and earned 833.43M in profits. Earnings per share was 64.49.
- Revenue
- 6.19B
- Gross Profit
- 2.51B
- Operating Income
- 1.15B
- Pretax Income
- 1.14B
- Net Income
- 833.43M
- EBITDA
- 1.74B
- Earnings Per Share (EPS)
- 64.49
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Japan Animal Referral Medical Center Co., Ltd. pays an annual dividend of JPY 8.00, resulting in a dividend yield of 1.24%
- Dividend Per Share
- JPY 8.00
- Dividend Yield
- 1.24%
- Payout Ratio
- 13.83%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 7.14%
Stock Price Statistics
- Beta
- 0.85
- 52-Week Price Change
- 2.22%
- 50-Day Moving Average
- 1007.60
- 200-Day Moving Average
- 1142.64
- Relative Strength Index (RSI)
- 38.18
- Average Volume (3m)
- 58.70K
Important Dates
Japan Animal Referral Medical Center Co., Ltd. upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- Mar 30, 2026
Financial Position
Japan Animal Referral Medical Center Co., Ltd. as a current ratio of 0.56, with Debt / Equity ratio of 105.69%
- Current Ratio
- 0.56
- Quick Ratio
- 0.54
- Debt to Market Cap
- 0.34
- Net Debt to EBITDA
- 2.05
- Interest Coverage Ratio
- 28.81
Taxes
In the past 12 months, Japan Animal Referral Medical Center Co., Ltd. has paid 308.59M in taxes.
- Income Tax
- 308.59M
- Effective Tax Rate
- 0.27
Enterprise Valuation
Japan Animal Referral Medical Center Co., Ltd. EV to EBITDA ratio is 9.09, with an EV/FCF ratio of 0.00.
- EV to Sales
- 2.58
- EV to EBITDA
- 9.09
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Japan Animal Referral Medical Center Co., Ltd. has JPY 1.25B in cash and marketable securities with JPY 5.16B in debt, giving a net cash position of -JPY 3.91B billion.
- Cash & Marketable Securities
- JPY 1.25B
- Total Debt
- JPY 5.16B
- Net Cash
- -JPY 3.91B
- Net Cash Per Share
- -JPY 271.37
- Tangible Book Value Per Share
- JPY 333.23
Margins
Gross margin is 41.58%, with operating margin of 19.50%, and net profit margin of 14.03%.
- Gross Margin
- 41.58%
- Operating Margin
- 19.50%
- Pretax Margin
- 19.35%
- Net Profit Margin
- 14.03%
- EBITDA Margin
- 28.37%
- EBIT Margin
- 19.50%
Analyst Forecast
The average price target for Japan Animal Referral Medical Center Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 15.68%
- EPS Growth Forecast
- 49.24%
Scores
- Smart Score
- ―
- AI Score
- 65
